Delayed Contrast Enhancement on MR Images of Myocardium

358 radiology.rsna.org n Radiology: Volume 261: Number 2—November 2011 1 From the Department of Radiology, UCSF Medical Center, 505 Parnassus Ave, Room L308, Box 0628, San Francisco, CA 94143-0628. Received October 14, 2009; revision requested November 17; revision received May 3, 2010; accepted May 14; fi nal version accepted May 27. Final review by K.G.O. May 14, 2011. Address correspondence to C.B.H. (e-mail: charles.higgins@radiology.ucsf.edu ).

[1]  C. Çevik,et al.  Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[3]  D. O’Regan,et al.  Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention. , 2009, American journal of physiology. Heart and circulatory physiology.

[4]  H. Sakahara,et al.  Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy. , 2009, Journal of cardiac failure.

[5]  I. Haber,et al.  Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot , 2009, Circulation.

[6]  R. Cury,et al.  Practical tips and tricks in cardiovascular computed tomography: diagnosis of myocardial infarction. , 2009, Journal of cardiovascular computed tomography.

[7]  A. Del Maschio,et al.  Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. , 2009, AJR. American journal of roentgenology.

[8]  W. Manning,et al.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. , 2009, The American journal of cardiology.

[9]  J. Mariani,et al.  Utility of myocardial fibrosis and fatty infiltration detected by cardiac magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia--a single centre experience. , 2008, Heart, lung & circulation.

[10]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[11]  Danny C. Kim,et al.  Images in cardiovascular medicine. Lyme carditis. , 2008, Circulation.

[12]  T. Xanthos,et al.  Cardiac implications of Lyme disease, diagnosis and therapeutic approach. , 2008, International journal of cardiology.

[13]  Michael Jerosch-Herold,et al.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[14]  H. Shimokawa,et al.  MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. , 2008, AJR. American journal of roentgenology.

[15]  Marcus Carlsson,et al.  Identification of residual ischemia, infarction, and microvascular impairment in revascularized myocardial infarction using 64-slice MDCT. , 2008, Contrast media & molecular imaging.

[16]  A. Paydar,et al.  Magnetic Resonance Imaging for Endomyocardial Fibrosis , 2008, Pediatric Cardiology.

[17]  Didier Revel,et al.  Assessment of acute myocardial infarction using MDCT after percutaneous coronary intervention: comparison with MRI. , 2008, AJR. American journal of roentgenology.

[18]  Matthew W. Martinez,et al.  Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. , 2008, International journal of cardiology.

[19]  Harumi Sakahara,et al.  The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. , 2008, Journal of cardiology.

[20]  E. DiBella,et al.  Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI. , 2008, Magnetic resonance imaging.

[21]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[22]  K. Klingel,et al.  Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome. , 2008, Circulation.

[23]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[24]  R. Kim,et al.  Performance of Delayed-Enhancement Magnetic Resonance Imaging With Gadoversetamide Contrast for the Detection and Assessment of Myocardial Infarction: An International, Multicenter, Double-Blinded, Randomized Trial , 2008, Circulation.

[25]  M. Gutberlet,et al.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. , 2008, Radiology.

[26]  K. Klingel,et al.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2008, Heart.

[27]  H. Kauczor,et al.  Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[28]  T. Smith,et al.  Fatal Loeffler's endocarditis due to hypereosinophilic syndrome , 2007, American journal of hematology.

[29]  C. Visser,et al.  Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[30]  Katherine C. Wu,et al.  Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.

[31]  C. Rochitte,et al.  Cardiac magnetic resonance in Chagas' disease. , 2007, Artificial organs.

[32]  S. Dymarkowski,et al.  Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging , 2007, European Radiology.

[33]  M. Fogel,et al.  Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease. , 2007, The Journal of thoracic and cardiovascular surgery.

[34]  T. Hackl,et al.  Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. , 2007, Journal of the American College of Cardiology.

[35]  R. Günther,et al.  Characterization of myocardial viability using MR and CT imaging , 2007, European Radiology.

[36]  David Saloner,et al.  Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media. , 2006, Journal of the American College of Cardiology.

[37]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[38]  R. Gilkeson,et al.  Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions. , 2006, Congenital heart disease.

[39]  Håkan Ahlström,et al.  Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. , 2006, Journal of the American College of Cardiology.

[40]  David Saloner,et al.  MR guidance of targeted injections into border and core of scarred myocardium in pigs. , 2006, Radiology.

[41]  W. Stevenson,et al.  Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.

[42]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[43]  C. Gaudio,et al.  Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. , 2006, Journal of the American College of Cardiology.

[44]  E. Nagel.  Faculty Opinions recommendation of Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. , 2006 .

[45]  N. Kelekis,et al.  Magnetic resonance imaging of the heart in a patient with hypereosinophilic syndrome. , 2006, The American journal of medicine.

[46]  D. Pennell,et al.  Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome , 2006, Circulation.

[47]  B. Mulder,et al.  Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. , 2005, Radiology.

[48]  J. Lima,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.

[49]  Fabien Hyafil,et al.  Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. , 2005, Radiology.

[50]  H. Crijns,et al.  The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. , 2005, Chest.

[51]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[52]  W. Dassen,et al.  Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. , 2005, Chest.

[53]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[54]  F. Salvi,et al.  Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance , 2005, Heart.

[55]  David O. Martin,et al.  Relationship Between Successful Ablation Sites and the Scar Border Zone Defined by Substrate Mapping for Ventricular Tachycardia Post‐Myocardial Infarction , 2005, Journal of cardiovascular electrophysiology.

[56]  G. Salanitri.  Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. , 2005, AJR. American journal of roentgenology.

[57]  Raymond J Kim,et al.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. , 2005, Journal of the American College of Cardiology.

[58]  C. Higgins,et al.  Long-Term Oral Treatment with Nicorandil Prevents the Progression of Left Ventricular Hypertrophy and Preserves Viability , 2005, Journal of cardiovascular pharmacology.

[59]  K. Takeda,et al.  Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. , 2005, Journal of the American College of Cardiology.

[60]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[61]  R. Falk,et al.  Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.

[62]  Hugh Calkins,et al.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[63]  S. Neubauer,et al.  Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance , 2004, Heart.

[64]  P. Poole‐Wilson,et al.  The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. , 2004, Journal of the American College of Cardiology.

[65]  T. Grist,et al.  Infiltrative Eosinophilic Myocarditis Diagnosed and Localized by Cardiac Magnetic Resonance Imaging , 2004 .

[66]  J. Schwitter,et al.  Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging. , 2004, Cardiology in review.

[67]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[68]  Eckart Fleck,et al.  Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery , 2004, Circulation.

[69]  S. Rose,et al.  Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[70]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[71]  Elliot R. McVeigh,et al.  Magnetic Resonance Fluoroscopy Allows Targeted Delivery of Mesenchymal Stem Cells to Infarct Borders in Swine , 2003, Circulation.

[72]  Dipan J. Shah,et al.  Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy , 2003, Circulation.

[73]  G. V. von Schulthess,et al.  Characterization of Dysfunctional Myocardium by Positron Emission Tomography and Magnetic Resonance: Relation to Functional Outcome After Revascularization , 2003, Circulation.

[74]  J. Schulz-Menger,et al.  Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. , 2003, Journal of the American College of Cardiology.

[75]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[76]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[77]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[78]  Raymond J Kim,et al.  Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? , 2003, Journal of the American College of Cardiology.

[79]  J. Schulz-Menger,et al.  Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging , 2003, Magnetic Resonance Materials in Physics, Biology and Medicine.

[80]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[81]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[82]  Maythem Saeed,et al.  Noninvasive assessment of the effects of nicorandil on left ventricular volumes and function in reperfused myocardial infarction. , 2002, Cardiovascular research.

[83]  B. Schnackenburg,et al.  Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[84]  P. Elliott,et al.  Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease , 2001, Circulation.

[85]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[86]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[87]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[88]  C M Kramer,et al.  Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. , 2000, Journal of the American College of Cardiology.

[89]  R. Kim,et al.  Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. , 2000, Journal of the American College of Cardiology.

[90]  G Thiene,et al.  Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. , 2000, Human pathology.

[91]  Katherine C. Wu,et al.  Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. , 2000, Circulation.

[92]  T. Lim,et al.  Application of breath‐hold T2‐weighted, first‐pass perfusion and gadolinium‐enhanced T1‐weighted MR imaging for assessment of myocardial viability in a pig model , 2000, Journal of magnetic resonance imaging : JMRI.

[93]  C. Higgins,et al.  Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. , 2000, Radiology.

[94]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[95]  T H Lim,et al.  MRI of myocardial infarction , 1999, Journal of magnetic resonance imaging : JMRI.

[96]  C. Higgins,et al.  Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. , 1999, Radiology.

[97]  J Sykes,et al.  Assessment of myocardial viability using MRI during a constant infusion of Gd‐DTPA: Further studies at early and late periods of reperfusion , 1999, Magnetic resonance in medicine.

[98]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[99]  C. Kramer,et al.  Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. , 1999, Circulation.

[100]  J Bogaert,et al.  Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. , 1999, Circulation.

[101]  R O Bonow,et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.

[102]  Katherine C. Wu,et al.  Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. , 1998, Journal of the American College of Cardiology.

[103]  C. Higgins,et al.  Toward necrotic cell fraction measurement by contrast-enhanced MRI of reperfused ischemically injured myocardium. , 1998, Academic radiology.

[104]  Katherine C. Wu,et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.

[105]  F. Prato,et al.  The determination of myocardial viability using Gd‐DTPA in a canine model of acute myocardial ischemia and reperfusion , 1996, Magnetic resonance in medicine.

[106]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[107]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[108]  C. Higgins,et al.  Identification of Myocardial Cell Death in Reperfused Myocardial Injury Using Dual Mechanisms of Contrast-Enhanced Magnetic Resonance Imaging , 1994 .

[109]  K. Yu,et al.  Identification of Myocardial Reperfusion With Echo Planar Magnetic Resonance Imaging: Discrimination Between Occlusive and Reperfused Infarctions , 1994, Circulation.

[110]  Maythem Saeed,et al.  Reperfused myocardial infarctions on T1‐ and susceptibility‐enhanced MRI: Evidence for loss of compartmentalization of contrast media , 1994, Magnetic resonance in medicine.

[111]  A. Movahed,et al.  Sarcoidosis of the Heart , 1993, Clinical cardiology.

[112]  W. Roberts,et al.  Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.

[113]  C. Higgins,et al.  Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging. , 1990, Radiology.

[114]  A. Wilde,et al.  Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. , 1990, Journal of the American College of Cardiology.

[115]  P. V. van Dijkman,et al.  Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA--enhanced MR imaging. , 1989, Radiology.

[116]  R. Swanton.  Sarcoidosis of the heart. , 1988, European heart journal.

[117]  J M de Bakker,et al.  Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. , 1988, Circulation.

[118]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.

[119]  D Tscholakoff,et al.  Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR imaging. , 1986, Radiology.

[120]  D Revel,et al.  Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. , 1986, Radiology.

[121]  R. Ehman,et al.  Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. , 1984, Radiology.

[122]  R. Ehman,et al.  ENHANCEMENT OF MYOCARDIAL INFARCTIONS WITH NUCLEAR MAGNETIC RESONANCE CONTRAST MEDIA , 1984 .

[123]  C. Higgins,et al.  1982 Memorial Award Paper. Detection of regional myocardial dysfunction during ischemia with computerized tomography: documentation and physiologic basis. , 1982, Investigative radiology.

[124]  C. Higgins,et al.  Contrast Enhancement of Myocardial Infarction: Dependence on Necrosis and Residual Blood Flow and the Relationship to Distribution of Scintigraphic Imaging Agents , 1982, Circulation.

[125]  R. Redington,et al.  Detection and Quantitation of Myocardial Infarction In Vivo Using Transmission Computed Tomography , 1981, Circulation.

[126]  S. Hessel,et al.  In vivo evaluation of experimental myocardial infarcts by ungated computed tomography. , 1981, AJR. American journal of roentgenology.

[127]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[128]  C. Higgins,et al.  Detection, quantitation and contrast enhancement of myocardial infarction utilizing computerized axial tomography: comparison with histochemical staining and 99mTc-pyrophosphate imaging. , 1978, Investigative radiology.

[129]  M. Cheitlin.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2009 .

[130]  B. Gerber.  [Comprehensive cardiac imaging using multidetector CT and magnetic resonance imaging]. , 2009, Bulletin et memoires de l'Academie royale de medecine de Belgique.

[131]  A. Arai,et al.  Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[132]  O. Vignaux.  Cardiac sarcoidosis: spectrum of MRI features. , 2005, AJR. American journal of roentgenology.

[133]  P. Kellman,et al.  Magnetic Resonance and Computed Tomographic Imaging Gadolinium Delayed Enhancement Cardiovascular Magnetic Resonance Correlates With Clinical Measures of Myocardial Infarction , 2004 .

[134]  C. Higgins,et al.  Comparison of late enhancement cardiovascular magnetic resonance and thallium SPECT in patients with coronary disease and left ventricular dysfunction. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[135]  H. Bosmans,et al.  Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI , 2004, European Radiology.

[136]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[137]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[138]  R. Geuns,et al.  Images in Cardiovascular Medicine , 2000 .